{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:49:37Z","timestamp":1790232577099,"version":"4.1.0"},"reference-count":39,"publisher":"American Association for Cancer Research (AACR)","issue":"10","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) develops in the chronically inflamed mucosa of patients infected with the bacterial pathogen Helicobacter pylori. Here we use patient material, primary gastric lymphoma cell cultures, and a preclinical model of the disease to examine the role of microRNA (miRNA)-mediated posttranscriptional regulation\u2014focusing in particular on miR-203 and its target ABL1\u2014in gastric MALT lymphomagenesis. Microarray-based miRNA expression profiling revealed a strong downregulation of the putative tumor suppressor miRNA miR-203 in human MALT lymphoma samples, which resulted from extensive promoter hypermethylation of the miR-203 locus and coincided with the dysregulation of the miR-203 target ABL1 in lymphoma biopsies compared with matched adjacent normal material from the same patients. Treatment of lymphoma B cells with demethylating agents led to increased miR-203 expression and the concomitant downregulation of ABL1, confirming the epigenetic regulation of this miRNA. Ectopic reexpression of miR-203 by transfection of a human lymphoma cell line or lentiviral transduction of explanted primary MALT lymphoma cells was sufficient to prevent tumor cell proliferation in vitro. Similarly, the treatment of primary MALT lymphoma cells with the ABL inhibitors imatinib and dasatinib prevented tumor cell growth. Finally, we show that the treatment of tumor-bearing mice with imatinib induces MALT lymphoma regression in a preclinical model of the disease, implicating ABL1 in MALT lymphoma progression. In summary, our results show that the transformation from gastritis to MALT lymphoma is epigenetically regulated by miR-203 promoter methylation and identify ABL1 as a novel target for the treatment of this malignancy. Cancer Res; 71(10); 3616\u201324. \u00a92011 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-3907","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T23:54:52Z","timestamp":1301615692000},"page":"3616-3624","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Epigenetic Silencing of MicroRNA-203 Dysregulates ABL1 Expression and Drives\n                    <i>Helicobacter<\/i>\n                    -Associated Gastric Lymphomagenesis"],"prefix":"10.1158","volume":"71","author":[{"given":"Vanessa J.","family":"Craig","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Institute of Molecular Cancer Research and 2Functional Genomics Center Z\u00fcrich, University of Z\u00fcrich, Z\u00fcrich; 3Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; and 4Department of Hematology, Oncology and Immunology, Philipps-University, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio B.","family":"Cogliatti","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Institute of Molecular Cancer Research and 2Functional Genomics Center Z\u00fcrich, University of Z\u00fcrich, Z\u00fcrich; 3Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; and 4Department of Hematology, Oncology and Immunology, Philipps-University, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Rehrauer","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Institute of Molecular Cancer Research and 2Functional Genomics Center Z\u00fcrich, University of Z\u00fcrich, Z\u00fcrich; 3Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; and 4Department of Hematology, Oncology and Immunology, Philipps-University, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"W\u00fcndisch","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Institute of Molecular Cancer Research and 2Functional Genomics Center Z\u00fcrich, University of Z\u00fcrich, Z\u00fcrich; 3Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; and 4Department of Hematology, Oncology and Immunology, Philipps-University, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Institute of Molecular Cancer Research and 2Functional Genomics Center Z\u00fcrich, University of Z\u00fcrich, Z\u00fcrich; 3Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; and 4Department of Hematology, Oncology and Immunology, Philipps-University, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2011,5,15]]},"reference":[{"key":"2022061702553573900_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/asheducation-2005.1.307","article-title":"Clinical presentation and management of marginal zone lymphomas","author":"Thieblemont","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2022061702553573900_bib2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrc1409","article-title":"MALT lymphoma: from morphology to molecules","volume":"4","author":"Isaacson","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2022061702553573900_bib3","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood.V99.7.2541","article-title":"Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial","volume":"99","author":"Bertoni","year":"2002","journal-title":"Blood"},{"key":"2022061702553573900_bib4","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1200\/JCO.2005.05.018","article-title":"State-of-the-art therapeutics: marginal-zone lymphoma","volume":"23","author":"Bertoni","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022061702553573900_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet"},{"key":"2022061702553573900_bib6","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","article-title":"Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication","volume":"23","author":"Wundisch","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022061702553573900_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood-2009-06-228015","article-title":"Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins","volume":"115","author":"Craig","year":"2010","journal-title":"Blood"},{"key":"2022061702553573900_bib8","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/leu.2010.76","article-title":"B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis","volume":"24","author":"Craig","year":"2010","journal-title":"Leukemia"},{"key":"2022061702553573900_bib9","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0002-9440(10)65521-6","article-title":"Expression of costimulatory molecules in low-grade mucosa-associated lymphoid tissue-type lymphomas in vivo","volume":"155","author":"Knorr","year":"1999","journal-title":"Am J Pathol"},{"key":"2022061702553573900_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9440(10)62052-4","article-title":"The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of helicobacter-induced mucosa-associated lymphoid tissue lymphoma","volume":"167","author":"Mueller","year":"2005","journal-title":"Am J Pathol"},{"key":"2022061702553573900_bib11","first-page":"1625","article-title":"Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice","volume":"152","author":"Enno","year":"1998","journal-title":"Am J Pathol"},{"key":"2022061702553573900_bib12","first-page":"217","article-title":"MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma","volume":"147","author":"Enno","year":"1995","journal-title":"Am J Pathol"},{"key":"2022061702553573900_bib13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1073\/pnas.242741699","article-title":"Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma","volume":"100","author":"Mueller","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061702553573900_bib14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/10428190802007734","article-title":"Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas","volume":"49","author":"Huynh","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"2022061702553573900_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.53.1.34","article-title":"Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series","volume":"53","author":"Fischbach","year":"2004","journal-title":"Gut"},{"key":"2022061702553573900_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"2022061702553573900_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"2022061702553573900_bib18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"key":"2022061702553573900_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"2022061702553573900_bib20","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061702553573900_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"2022061702553573900_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"O'Donnell","year":"2005","journal-title":"Nature"},{"key":"2022061702553573900_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0014-2964(81)90060-8","article-title":"Variant translocation in a nonendemic case of Burkitt's lymphoma: t (8;22) in an Epstein\u2013Barr virus negative tumour and in a derived cell line","volume":"17","author":"Bertrand","year":"1981","journal-title":"Eur J Cancer"},{"key":"2022061702553573900_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2022061702553573900_bib25","first-page":"6931","article-title":"ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors","volume":"61","author":"Sun","year":"2001","journal-title":"Cancer Res"},{"key":"2022061702553573900_bib26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.nbd.2004.06.007","article-title":"Activation of the neuronal c-Abl tyrosine kinase by amyloid-beta-peptide and reactive oxygen species","volume":"17","author":"Alvarez","year":"2004","journal-title":"Neurobiol Dis"},{"key":"2022061702553573900_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccr.2008.04.018","article-title":"Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression","volume":"13","author":"Bueno","year":"2008","journal-title":"Cancer Cell"},{"key":"2022061702553573900_bib28","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.89.5.1827","article-title":"A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands","volume":"89","author":"Frommer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061702553573900_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ijc.25348","article-title":"MicroRNA signatures in Helicobacter pylori-infected gastric mucosa","volume":"128","author":"Matsushima","year":"2011","journal-title":"Int J Cancer"},{"key":"2022061702553573900_bib30","article-title":"miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma","author":"Furuta","year":"2009","journal-title":"Carcinogenesis"},{"key":"2022061702553573900_bib31","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/hep.22256","article-title":"MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene\/tumor suppressor gene mutations","volume":"47","author":"Ladeiro","year":"2008","journal-title":"Hepatology"},{"key":"2022061702553573900_bib32","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1158\/0008-5472.CAN-06-2698","article-title":"Characterization of microRNA expression levels and their biological correlates in human cancer cell lines","volume":"67","author":"Gaur","year":"2007","journal-title":"Cancer Res"},{"key":"2022061702553573900_bib33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/nar\/gki200","article-title":"Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis","volume":"33","author":"Cheng","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2022061702553573900_bib34","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/cdd.2008.69","article-title":"miR-203 represses \u2018stemness\u2019 by repressing DeltaNp63","volume":"15","author":"Lena","year":"2008","journal-title":"Cell Death Differ"},{"key":"2022061702553573900_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/asheducation-2005.1.118","article-title":"Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia","author":"Ottmann","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2022061702553573900_bib36","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0092-8674(91)90012-N","article-title":"Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations","volume":"65","author":"Schwartzberg","year":"1991","journal-title":"Cell"},{"key":"2022061702553573900_bib37","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.4049\/jimmunol.165.12.6872","article-title":"The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19","volume":"165","author":"Zipfel","year":"2000","journal-title":"J Immunol"},{"key":"2022061702553573900_bib38","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1158\/0008-5472.CAN-05-3901","article-title":"c-Abl expression in chronic lymphocytic leukemia cells: clinical and therapeutic implications","volume":"66","author":"Lin","year":"2006","journal-title":"Cancer Res"},{"key":"2022061702553573900_bib39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1125951","article-title":"Targeting tyrosine kinases in cancer: the second wave","volume":"312","author":"Baselga","year":"2006","journal-title":"Science"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/10\/3616\/2650664\/3616.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/71\/10\/3616\/2650664\/3616.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T07:37:17Z","timestamp":1655451437000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/71\/10\/3616\/567571\/Epigenetic-Silencing-of-MicroRNA-203-Dysregulates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,15]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,5,15]]},"published-print":{"date-parts":[[2011,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-3907","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6501978.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22387662","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22387659.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22387662.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22387659","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6501978","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,15]]}}}